Source: f11photo/Shutterstock.com
It’s time to start off the day with a breakdown of the biggest pre-market stock movers for Tuesday morning!
Moving stocks this morning are clinical trial data, a business combination, and the death of a company’s CFO.
Let’s dive into that news below!
Pre-Market Stock Movers: 10 Top Gainers
- IVERIC bio (NASDAQ:ISEE) stock is rocketing more than 38% following from its Phase 3 clinical trial.
- First Wave BioPharma (NASDAQ:FWBI) shares are soaring over 26% in pre-marketing trading today.
- Golden Sun Education (NASDAQ:GSUN) stock is gaining more than 19% this morning.
- Organovo (NASDAQ:ONVO) shares are increasing roughly 19% despite a lack of news.
- Rubius Therapeutics (NASDAQ:RUBY) stock is climbing over 17% alongside heavy trading.
- GlycoMimetics (NASDAQ:GLYC) shares are surging more than 15% after adding Edwin Rock .
- BitNile (NYSEMKT:NILE) stock is rising over 15% .
- CytomX Therapeutics (NASDAQ:CTMX) shares are jumping more than 13% on no clear news.
- Tian Ruixiang (NASDAQ:TIRX) stock is getting an over 12% boost in pre-market trading.
- NLS Pharmaceutics (NASDAQ:NLSP) shares are up more than 11% today.
10 Top Losers
- Creatd (NASDAQ:CRTD) stock is plummeting over 23% after getting a .
- Digital World Acquisition (NASDAQ:DWAC) shares are diving close to 19% on with Truth Social.
- Bed Bath & Beyond (NASDAQ:BBBY) stock is tumbling more than 16% following .
- Kuke Music (NYSE:KUKE) shares are taking an over 14% beating on no apparent news.
- PaxMedica (NASDAQ:PXMD) stock is sliding more than 14% after rallying on Friday.
- Burcon NutraScience (NASDAQ:BRCN) shares are dropping over 12% on .
- Golden Ocean (NASDAQ:GOGL) stock is decreasing more than 11% after announcing the .
- Icecure Medical (NASDAQ:ICCM) shares are slipping over 11% after .
- Boxlight (NASDAQ:BOXL) stock is dipping more than 10% this morning.
- Advanced Human Imaging (NASDAQ:AHI) shares close out our pre-market stock movers down over 10% after a .
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.